Jump to content

Integrative Cancer Therapies: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m adding website
adding IF
Line 13: Line 13:
| openaccess =
| openaccess =
| license =
| license =
| impact =
| impact = 2.264
| impact-year =
| impact-year = 2008
| website = http://ict.sagepub.com
| website = http://ict.sagepub.com
| link1 =
| link1 =

Revision as of 21:09, 16 January 2010

Integrative Cancer Therapies
DisciplineMedicine
LanguageEnglish
Edited byKeith I. Block
Publication details
History2002-present
Publisher
FrequencyQuarterly
2.264 (2008)
Standard abbreviations
ISO 4Integr. Cancer. Ther.
Indexing
ISSN1534-7354 (print)
1552-695X (web)
Links

Integrative Cancer Therapies is a scientific journal focusing on complementary and alternative medicine and integrative medicine in the care for and treatment of patients with cancer. Therapies like diets and lifestyle modifications, as well as experimental vaccines and chemotherapy are the subject of this journal. Launched by SAGE Publications, the first issue was published in March 2002. Current chief editor is Keith I. Block, MD.

A study published in the March 2006 issue, Diagnostic Accuracy of Canine Scent Detection in Early-and Late-Stage Lung and Breast Cancers by McCulloch et al. garnered worldwide media attention.[1][2] The study presented evidence that a dog's extraordinary scenting ability can distinguish people with both early and late stage lung and breast cancers from healthy controls.[3]

References

  1. ^ "Can Dogs Smell Cancer?". ScienceDaily. 2006-01-06. Retrieved 2010-01-16. {{cite web}}: Cite has empty unknown parameter: |coauthors= (help)
  2. ^ "Can Dogs Sniff Out Cancer? Studies Show They Probably Can". Medical News Today. 2006-01-07. Retrieved 2010-01-16. {{cite web}}: Cite has empty unknown parameter: |coauthors= (help)
  3. ^ McCulloch, Michael; Jezierski, Tadeusz; Broffman, Michael; Hubbard, Alan; Turner, Kirk; Janecki, Teresa (2006), "Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers", Integr Cancer Ther, 5 (1): 30–39, doi:10.1177/1534735405285096, PMID 16484712